Results for tag: "Cholecystokinin"

Cholecystokinin (CCK) is a gastrointestinal hormone that plays a role in digestion and appetite regulation. It is released by the small intestine in response to the presence of fat and protein in the digestive tract. CCK stimulates the release of digestive enzymes from the pancreas and bile from the gallbladder, and it also helps to regulate appetite by sending signals to the brain that the stomach is full. CCK is used in the treatment of gastrointestinal disorders such as irritable bowel syndrome, gastroparesis, and pancreatitis. It is also used to reduce nausea and vomiting associated with chemotherapy and radiation therapy. The CCK market is a subset of the larger gastrointestinal drugs market. It is composed of pharmaceutical companies that develop and market CCK-based drugs for the treatment of gastrointestinal disorders. These companies are focused on developing new and improved treatments for gastrointestinal diseases, as well as improving existing treatments. Examples of companies in the CCK market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more